SEKISUI has agreed to divest SEKISUI Virotech GmbH in a stock sale to Virotech Diagnostics Holdings GmbH. The purchase price was not disclosed.
SEKISUI Virotech is being purchased as an intact operating unit, which therefore includes the entire business, assets and all personnel. The company will operate under the name Virotech Diagnostics GmbH. The Stock Purchase Agreement has been signed as of November 11, with a target closing date of November 30, 2016, subject to customary approvals. Business will continue as normal throughout the transition, and product supply will continue with no anticipated interruption, with Virotech continuing their high levels of customer service and support.
